Skip to main content
. 2024 Mar 4;13:13. doi: 10.1186/s13741-024-00369-9

Table 2.

Patient and surgical characteristics in the single-arm trial and contemporaneous comparison group

Contemporaneous
comparison
N = 15,796
Trial
N = 457
Standardized mean difference
Age, years 64.0 [54.0, 72.0] 65.0 [56.0, 72.0] 0.107
Male Sexa 8838 (56.0) 237 (51.9) 0.083
Race 0.172
 White 12192 (77.2) 377 (82.5)
 Black 1417 (9.0) 37 (8.1)
 Asian or Pacific Islander 698 (4.4) 18 (3.9)
 Other 131 (0.8) 4 (0.9)
 Unknown 1358 (8.6) 21 (4.6)
Hispanic or Latino ethnicity 314 (2.0) 6 (1.3) 0.053
ASA Physical Status Class IV 2186 (13.8) 40 (8.8) 0.161
Vanwalraven Elixhauser Comorbidity Index 11.0 [4.0, 19.0] 11.0 [3.0, 17.0] 0.094
 AIDS/HIVb 47 (0.3) 1 (0.2) 0.017
 Alcohol abuseb 294 (1.9) 4 (0.9) 0.085
 Blood loss anemiab 378 (2.4) 7 (1.5) 0.063
 Cardiac arrhythmiasb 5451 (34.5) 108 (23.6) 0.244
 Chronic pulmonary diseaseb 3606 (22.8) 87 (19.0) 0.095
 Congestive heart failurec 1744 (11.0) 33 (7.2) 0.134
 Coagulopathyd 1900 (12.0) 32 (7.0) 0.173
 Deficiency anemiad 689 (4.4) 15 (3.3) 0.058
 Depressiond 2964 (18.8) 86 (18.8) 0.010
 Diabetes complicatedc 1382 (8.7) 36 (7.9) 0.033
 Diabetes uncomplicatedc 2703 (17.1) 89 (19.5) 0.061
 Drug abused 727 (4.6) 11 (2.4) 0.120
 Fluid electrolyte disordersd 4978 (31.5) 116 (25.4) 0.138
 Hypertension, complicatedd 3008 (19.0) 74 (16.2) 0.077
 Hypertension, uncomplicatedd 8132 (51.5) 242 (53.0) 0.030
 Hypothyroidismd 2388 (15.1) 66 (14.4) 0.022
 Liver diseased 1696 (10.7) 65 (14.2) 0.106
 Lymphomad 225 (1.4) 8 (1.8) 0.028
 Metastatic cancerd 3183 (20.2) 121 (26.5) 0.150
 Obesityd 3631 (23.0) 117 (25.6) 0.061
 Other neurologic disordersd 1953 (12.4) 24 (5.3) 0.254
 Paralysisd 602 (3.8) 7 (1.5) 0.142
 Peptic ulcer disease excluding bleedingd 258 (1.6) 7 (1.5) 0.013
 Peripheral vascular disordersd 2709 (17.1) 58 (12.7) 0.127
 Psychosesd 165 (1.0) 4 (0.9) 0.020
 Pulmonary circulation disordersd 959 (6.1) 17 (3.7) 0.110
 Renal failured 2777 (17.6) 71 (15.5) 0.057
 Rheumatoid arthritis/collagen vascular diseasesd 654 (4.1) 15 (3.3) 0.047
 Solid tumor without metastasisd 6578 (41.6) 209 (45.7) 0.083
 Valvular diseased 1284 (8.1) 18 (3.9) 0.178
 Weight lossd 2291 (14.5) 58 (12.7) 0.055
Procedure started in afternoond 5204 (32.9) 133 (29.1) 0.105
Procedural service 0.856
 General 1971 (12.5) 124 (27.1)
 Orthopedics 1955 (12.4) 61 (13.3)
 Urology 1136 (7.2) 56 (12.3)
 Neurosurgery 4168 (26.4) 47 (10.3)
 Vascular 1483 (9.4) 33 (7.2)
 Transplant 877 (5.6) 23 (5.0)
 Otolaryngology 1129 (7.1) 17 (3.7)
 Obstetrics and gynecology 353 (2.2) 8 (1.8)
 Oral/maxillofacial 95 (0.6) 5 (1.1)
 Plastics 181 (1.1) 4 (0.9)
 Cardiac 93 (0.6) 2 (0.4)
 Colorectal 41 (0.3) 1 (0.2)
 Surgery-oncology 25 (0.2) 1 (0.2)
 Trauma 115 (0.7) 1 (0.2)
 Thoracic 1192 (7.5) 1 (0.2)
 Radiology 74 (0.5) 0 (0.0)
 Cardiothoracic 185 (1.2) 0 (0.0)
 Pain management 20 (0.1) 0 (0.0)
 Surgical service-other 673 (4.3) 70 (15.3)
 Other 30 (0.2) 3 (0.7)

ASA American Society of Anesthesiologists: HIV human immunodeficiency virus: AIDS acquired immunodeficiency syndrome

Data is presented as median [quartile 1, quartile 3] or n (%) depending on the variable type

aMissing for 1 patient in the comparison group

bMissing for 435 patients in the comparison group and 12 patients in the trial

cMissing for 437 patients in the comparison group and 12 patients in the trial

dMissing for 441 patients in the comparison group and 12 patients in the trial

dMissing for 1 patient in the trial